Histone variants and melanoma: facts and hypotheses
Authors:
- 11 May 2016
- journal article
- review article
- Published by Wiley in Pigment Cell & Melanoma Research
- Vol. 29 (4) , 426-433
Abstract
Melanoma is the most aggressive form of skin cancer with rising incidence and morbidity. Despite advances in treatment, the 10-yr survival for patients with metastatic disease is less than 10%. During the past few years, ongoing research on different epigenomic aberrations in melanoma has catalyzed better understanding of its pathogenesis and identification of new therapeutics. In our review, we will focus on the role of histone variants, key epigenetic players in melanoma initiation and progression. Specifically, incorporation of histone variants enables additional layers of chromatin structure, and here, we will describe how alterations in this epigenetic behavior impact melanoma.Keywords
This publication has 102 references indexed in Scilit:
- Genetics and epigenetics of cutaneous malignant melanoma: A concert out of tuneBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2012
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomasNature Genetics, 2012
- The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onsetNature, 2011
- The histone variant macroH2A suppresses melanoma progression through regulation of CDK8Nature, 2010
- Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic RegionsCell, 2010
- Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanomaOncogene, 2009
- CpG islands – ‘A rough guide’FEBS Letters, 2009
- Neocentromeres: New Insights into Centromere Structure, Disease Development, and Karyotype EvolutionThe American Journal of Human Genetics, 2008
- High-Resolution Profiling of Histone Methylations in the Human GenomeCell, 2007
- The language of covalent histone modificationsNature, 2000